Eicosapentaenoic Acid-d5

(2R,4S)-5-(联苯-4-基)-4-[(叔丁氧基羰基)氨基]-2-甲基戊酸;LCZ696中间体2;(2R,4S)-5-(联苯-4-基)-4-[(叔丁氧羰基)氨基]-2-甲基戊酸;(2R,4S)-5-([1,1′-联苯]-4-基)-4-((叔丁氧羰基)氨基)-2-甲基戊酸;(2R,4S)-5-([1,1'-联苯]-4-基)-4-((叔丁氧羰基)氨基)-2-甲基戊酸;3,4,5,6-四氢-5-氧代-2,6-萘啶-2(1H)-羧酸叔丁酯;LCZ696 中间体N-3;LCZ696中间体;盐酸胍法辛;原研547-06;LCZ969中间体;LCZ-696中间体三;LCZ696中间体AHU;LCZ696 医药中间体Ⅰ;LCZ-696中间体40(R,R);LCZ696(ENTRESTO)中间体甲基戊酸;2R,4S)-5-(联苯-4-基)-4-[(叔丁氧基羰基)氨基]-2-甲基戊酸

Eicosapentaenoic Acid-d5

(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid;LCZ696 inter.;(2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid;LCZ696 intermediate2;LCZ696 Intermediate1;sacubitril;Valsartan;LCZ696 INT;AHU;AHU08;LCA696 inter;sacubitril intermediate;LCZ-696 Intermediate 40(R,R);1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid;(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic;(2R,4S)-5-biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methylpentanoic acid;(2R,4S)-5-((1,1'-Biphenyl)-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid;YNELJETWNMPEEH-UZLBHIALSA-N;AK318470;AMBZ0395;(2R,4S)-5-([1,1-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid;M

1197205-73-4

C₂₃H₂₉NO₄

383.48